Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 58 results.
User Information
Export Records
  1. 1.   Unraveling the dynamics of B7-H3-targeting therapeutic antibodies in cancer through PET imaging and antibody pharmacokinetics
  2. Fernandes, Bruna; Olkowski, Colleen P; Ghaemi, Behnaz; Basuli, Falguni; Shi, Jianfeng; Kiesewetter, Dale O; Lang, Lixin; Elijah, Edmondson; Swenson, Rolf; Choyke, Peter L; Lin, Frank I; Jacobson, Orit
  3. Journal of Controlled Release : official journal of the Controlled Release Society. 2025, Jan 13;
  1. 2.   Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
  2. Feng,Yang; Lee,Jaewon; Yang,Liping; Hilton,Mary; Morris,Karen; Seaman,Steven; Edupuganti,Shivaji; Hsu,Kuo-Sheng; Dower, Christopher; Yu,Guojun; So,Daeho; Bajgain,Pradip; Zhu, Zhongyu; Dimitrov, Dimiter S; Patel,Nimit; Robinson,Christina; Difilippantonio,Simone; Dyba,Marzena; Corbel,Amanda; Basuli, Falguni; Swenson, Rolf E; Kalen,Joseph; Suthe, Sreedhar Reddy; Hussain, Myer; Italia, James S; Souders, Colby A; Gao, Ling; Schnermann,Martin; St Croix,Brad
  3. Cell Reports. 2023, Nov 28; 42(12): 113503.
  1. 3.   Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody
  2. Lee, Myungeun; Lu, Zhi Hong; Shoemaker, Charles B.; Tremblay, Jacqueline M.; St Croix,Brad; Seaman,Steven; Gonzalez-Pastor, Rebeca; Kashentseva, Elena A.; Dmitriev, Igor P.; Curiel, David T.
  3. Journal of Controlled Release : Official Journal of the Controlled Release Society. 2021, Jun 10; 334: 106-113.
  1. 4.   The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models
  2. Kendsersky, Nathan M.; Lindsay, Jarrett; Kolb, E. Anders; Smith, Malcolm A.; Teicher, Beverly A.; Erickson, Stephen W.; Earley, Eric J.; Mosse, Yael P.; Martinez, Daniel; Pogoriler, Jennifer; Krytska, Kateryna; Patel, Khushbu; Groff, David; Tsang, Matthew; Ghilu, Samson; Wang, Yifei; Seaman,Steven; Feng,Yang; St Croix,Brad; Gorlick, Richard; Kurmasheva, Raushan; Houghton, Peter J.; Maris, John M.
  3. CLINICAL CANCER RESEARCH. 2021, May 15; 27(10): 2938-2946.
  1. 5.   3,7-Dihydroxytropolones Inhibit Initiation of Hepatitis B Virus Minus-Strand DNA Synthesis
  2. Bak, Ellen; Miller,Jennifer; Noronha, Andrea; Tavis, John; Gallicchio, Emilio; Murelli, Ryan P; Le Grice,Stuart
  3. Molecules (Basel, Switzerland). 2020, OCT; 25(19): pii: E4434.
  1. 6.   Isolation of rabbit single domain antibodies to B7-H3 via protein immunization and phage display
  2. Feng, Ruonan; Wang, Ruixue; Hong, Jessica; Dower,Chris; St Croix,Brad; Ho, Mitchell
  3. Antibody therapeutics. 2020, Jan; 3(1): 10-17.
  1. 7.   Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization
  2. Chen, X. H.; Peer, C. J.; Alfaro, R.; Tian, T.; Spencer, S. D.; Figg, W. D.
  3. Journal of Pharmaceutical and Biomedical Analysis. 2012, Mar; 62: 140-148.
  1. 8.   Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10
  2. Rodriguez-Garcia, M.; Porichis, F.; de Jong, O. G.; Levi, K.; Diefenbach, T. J.; Lifson, J. D.; Freeman, G. J.; Walker, B. D.; Kaufmann, D. E.; Kavanagh, D. G.
  3. Journal of Leukocyte Biology. 2011, Apr; 89(4): 507-515.
  1. 9.   Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
  2. Kummar, S.; Gutierrez, M. E.; Gardner, E. R.; Chen, X. H.; Figg, W. D.; Zajac-Kaye, M.; Chen, M.; Steinberg, S. M.; Muir, C. A.; Yancey, M. A.; Horneffer, Y. R.; Juwara, L.; Melillo, G.; Ivy, S. P.; Merino, M.; Neckers, L.; Steeg, P. S.; Conley, B. A.; Giaccone, G.; Doroshow, J. H.; Murgo, A. J.
  3. European Journal of Cancer. 2010, Jan; 46(2): 340-347.
  1. 10.   HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF(165)
  2. Lambert, S.; Bouttier, M.; Vassy, R.; Seigneuret, M.; Petrow-Sadowski, C.; Janvier, S.; Heveker, N.; Ruscetti, F. W.; Perret, G.; Jones, K. S.; Pique, C.
  3. Blood. 2009 113(21): 5176-5185.
  1. 11.   Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation
  2. Miao, J.; Xiao, Z.; Kanamaluru, D.; Min, G.; Yau, P. M.; Veenstra, T. D.; Ellis, E.; Strom, S.; Suino-Powell, K.; Xu, H. E.; Kemper, J. K.
  3. Genes & Development. 2009 23(8): 986-996.
  1. 12.   Effect of Tumor Necrosis Factor-alpha on Estrogen Metabolism and Endometrial Cells: Potential Physiological and Pathological Relevance
  2. Salama, S. A.; Kamel, M. W.; Diaz-Arrastia, C. R.; Xu, X.; Veenstra, T. D.; Salih, S.; Botting, S. K.; Kumar, R.
  3. Journal of Clinical Endocrinology & Metabolism. 2009 94(1): 285-293.
  1. 13.   Relaxing Effects of Phytoestrogen alpha-Zearalanol on Rat Thoracic Aorta Rings in Vitro
  2. Wang, W.; Jiang, D. Q.; Zhu, Y. F.; Liu, W.; Duan, J. H.; Dai, S. L.
  3. Chinese Journal of Physiology. 2009 52(2): 99-105.
  1. 14.   Mutational Analysis and Allosteric Effects in the HIV-1 Capsid Protein Carboxyl-Terminal Dimerization Domain
  2. Yu, X.; Wang, Q. M.; Yang, J. C.; Buch, I.; Tsai, C. J.; Ma, B. Y.; Cheng, S.; Nussinov, R.; Zheng, J.
  3. Biomacromolecules. 2009 10(2): 390-399.
  1. 15.   Synthesis and biological evaluation of 2-amino-3-(3 ',4 ',5 '-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridi ne derivatives as antimitotic agents and inhibitors of tubulin polymerization
  2. Romagnoli, R.; Baraldi, P. G.; Carrion, M. D.; Cruz-Lopez, O.; Cara, C. L.; Tolomeo, M.; Grimaudo, S.; Di Cristina, A.; Pipitone, M. R.; Balzarini, J.; Kandil, S.; Brancale, A.; Sarkar, T.; Hamel, E.
  3. Bioorganic & Medicinal Chemistry Letters. 2008 18(18): 5041-5045.
  1. 16.   Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta(2)-adrenergic receptor
  2. Shenoy, S. K.; Xiao, K. H.; Venkataramanan, V.; Snyder, P. M.; Freedman, N. J.; Weissman, A. M.
  3. Journal of Biological Chemistry. 2008 283(32): 22166-22176.
  1. 17.   Determination of 17-dimethylaminoethylamino-17-demethoxygeldanamycin in human plasma by liquid chromatography with mass-spectrometric detection
  2. Chen, X.; Gardner, E. R.; Gutierrez, M.; Kummar, S.; Figg, W. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2007, Oct; 858(1-2): 302-306.
  1. 18.   High-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes
  2. Edgar, R.; McKinstry, M.; Hwang, J.; Oppenheim, A. B.; Fekete, R. A.; Giulian, G.; Merril, C.; Nagashima, K.; Adhya, S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, Mar; 103(13): 4841-4845.
  1. 19.   Multifunctional roles of the conserved arg residues in the second region of homology of p97/valosin-containing protein
  2. Wang, Q.; Song, C. C.; Irizarry, L.; Dai, R. M.; Zhang, X. D.; Li, C. C. H.
  3. Journal of Biological Chemistry. 2005, DEC 9; 280(49): 40515-40523.
  1. 20.   Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis
  2. Le, Y. Y.; Ye, R. D.; Gong, W. H.; Li, J. X.; Iribarren, P.; Wang, J. M.
  3. Febs Journal. 2005, FEB; 272(3): 769-778.
  1. 21.   Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic
  2. Oishi, S.; Karki, R. G.; Shi, Z. D.; Worthy, K. M.; Bindu, L.; Chertov, O.; Esposito, D.; Frank, P.; Gillette, W. K.; Maderia, M.; Hartley, J.; Nicklaus, M. C.; Barchi, J. J.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry. 2005 13(7): 2431-2438.
  1. 22.   Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-I alpha responses
  2. Sloane, A. J.; Raso, V.; Dimitrov, D. S.; Xiao, X. D.; Deo, S.; Muljadi, N.; Restuccia, D.; Turville, S.; Kearney, C.; Broder, C. C.; Zoellner, H.; Cunningham, A. L.; Bendall, L.; Lynch, G. W.
  3. Immunology and Cell Biology. 2005 83(2): 129-143.
  1. 23.   Role of the beta 7-beta 8-loop in the 51kDa subunit of HIV-1 reverse transcriptase in protein stability and drug resistance
  2. Sluis-Cremer, N.; Radzio, J.; Camarasa, M. J.; Tachedjian, G.; Nissley, D.
  3. Antiviral Therapy. 2005 10(4): S99-S99.
  1. 24.   Enhanced tumor cell radiosensitivity and abrogation of G(2) and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
  2. Bull, E. E. A.; Dote, H.; Brady, K. J.; Burgan, W. E.; Carter, D. J.; Cerra, M. A.; Oswald, K. A.; Hollingshead, M. G.; Camphausen, K.; Tofilon, P. J.
  3. Clinical Cancer Research. 2004, DEC 1; 10(23): 8077-8084.
  1. 25.   Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions
  2. Wang, Q.; Song, C. C.; Li, C. C. H.
  3. Journal of Structural Biology. 2004, APR-MAY; 146(1-2): 44-57.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel